Table 4.
Univariate and multivariable analyses for predictors of secondary endpoint
| Univariate analysis |
Multivariable analysis |
Resampling procedure | |||
|---|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | Frequency | |
| Diabetes | 1.50 (0.79–2.85) | 0.211 | |||
| QRS >110 ms | 2.32 (1.13–4.77) | 0.022 | 2.39 (1.11–5.12) | 0.026 | 0.86 |
| QTc >440 ms | 1.74 (1.01–2.99) | 0.046 | 1.76 (1.01–3.07) | 0.047 | 0.70 |
| LVEDVI | 1.00 (1.00–1.01) | 0.009 | 0.28 | ||
| RVEDVI | 1.01 (1.00–1.02) | 0.008 | 1.01 (1.0–1.02) | 0.010 | 0.76 |
| CI | 0.72 (0.48–1.06) | 0.096 | |||
| LVEF | 0.97 (0.94–0.99) | 0.005 | 0.61 | ||
| RVEF | 0.98 (0.96–1.00) | 0.040 | 0.32 | ||
| LGE | 1.45 (0.82–2.58) | 0.202 | |||